Nektar Therapeutics | NKTR - Loan Capital


Nektar Therapeutics reported $107.51M in Loan Capital for its fiscal quarter ending in June of 2024.





Loan Capital Change Date
Agios Pharmaceuticals USD 1.06M 0 Sep/2022
ALKERMES USD 285.82M 639K Sep/2024
Alterity Therapeutics Limited AUD 103.21K 73.88K Jun/2023
Amgen USD 50B 2.43B Dec/2025
Baxter International USD 9.47B 726M Dec/2025
BioCryst Pharmaceuticals USD 428.67M 234.31M Dec/2025
Biogen USD 6.29B 1.4M Sep/2025
Bristol-Myers Squibb USD 42.85B 1.62B Dec/2025
Cara Therapeutics USD 0 0 Mar/2025
Cipla INR 2.98B 454.6M Sep/2025
Dr.Reddys Laboratories INR 11.61B 29M Dec/2025
Eisai JPY 134.77B 12M Dec/2025
Eli Lilly USD 40.87B 5.6M Dec/2025
Esperion Therapeutics USD 457.65M 9.5M Dec/2025
Gilead Sciences USD 22.14B 5M Sep/2025
GlaxoSmithKline GBP 14.71B 186M Dec/2025
Grifols EUR 9.95B 722.93M Dec/2025
Halozyme Therapeutics USD 2.14B 1.34B Dec/2025
Incyte USD 30.2M 5.17M Dec/2025
Ionis Pharmaceuticals USD 1.9B 1.87B Dec/2025
Ironwood Pharmaceuticals USD 583.99M 14.83M Dec/2024
Karyopharm Therapeutics USD -0.93 0.67 Dec/2024
MacroGenics USD 70M 256K Dec/2025
Merck USD 39.97B 6B Sep/2025
Nektar Therapeutics USD 107.51M 10.35M Jun/2024
Neurocrine Biosciences USD 169.5M 500K Mar/2023
Novartis USD 29.59B 5.35B Dec/2025
Pfizer USD 57.41B 93M Sep/2025
Roche Holding CHF 27.43B 966M Dec/2025
Sarepta Therapeutics USD 828.97M 206.17M Dec/2025
Takeda JPY 4.27T 81.29B Dec/2025
Teva Pharmaceutical Industries USD 14.99B 1.78B Dec/2025
Xencor USD 76.48M 11.29M Dec/2025